Korsana Biosciences, Inc. (KRSA)
32.83
-2.16
(-6.17%)
USD |
NASDAQ |
Sep 21, 16:00
33.09
+0.26
(+0.79%)
After-Hours: 20:00
Korsana Biosciences Price to Book Value : 3.924 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 4.182 |
| September 17, 2026 | 4.030 |
| September 16, 2026 | 3.733 |
| September 15, 2026 | 3.834 |
| September 14, 2026 | 3.778 |
| September 11, 2026 | 3.813 |
| September 10, 2026 | 2.935 |
| September 09, 2026 | 3.131 |
| September 08, 2026 | 2.811 |
| September 04, 2026 | 3.556 |
| September 03, 2026 | 4.150 |
| September 02, 2026 | 3.782 |
| September 01, 2026 | 3.489 |
| August 31, 2026 | 3.079 |
| August 28, 2026 | 3.171 |
| August 27, 2026 | 3.338 |
| August 26, 2026 | 3.472 |
| August 25, 2026 | 3.347 |
| August 24, 2026 | 3.288 |
| August 21, 2026 | 3.254 |
| August 20, 2026 | 3.405 |
| August 19, 2026 | 3.455 |
| August 18, 2026 | 3.447 |
| August 17, 2026 | 3.372 |
| August 14, 2026 | 3.171 |
| Date | Value |
|---|---|
| August 13, 2026 | 3.271 |
| August 12, 2026 | 3.280 |
| August 11, 2026 | 2.987 |
| August 10, 2026 | 2.995 |
| August 07, 2026 | 2.987 |
| August 06, 2026 | 2.978 |
| August 05, 2026 | 2.970 |
| August 04, 2026 | 2.937 |
| August 03, 2026 | 2.920 |
| July 31, 2026 | 2.878 |
| July 30, 2026 | 2.928 |
| July 29, 2026 | 2.928 |
| July 28, 2026 | 2.928 |
| July 27, 2026 | 2.928 |
| July 24, 2026 | 2.928 |
| July 23, 2026 | 3.029 |
| July 22, 2026 | 3.037 |
| July 21, 2026 | 3.091 |
| July 20, 2026 | 3.054 |
| July 17, 2026 | 3.045 |
| July 16, 2026 | 3.062 |
| July 15, 2026 | 3.104 |
| July 14, 2026 | 3.204 |
| July 13, 2026 | 3.196 |
| July 10, 2026 | 3.208 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Climb Bio, Inc. | 3.267 |
| Q32 Bio, Inc. | 2.349 |
| Arrowhead Pharmaceuticals, Inc. | 20.86 |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 9.566 |
| PEG Ratio | -0.0221 |
| Price | 32.83 |
| Earnings Yield | -35.82% |
| Market Cap | 19.96M |
| PEGY Ratio | -0.0221 |